Oregon Public Employees Retirement Fund lowered its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) by 4.8% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 19,675 shares of the biotechnology company’s stock after selling 983 shares during the quarter. Oregon Public Employees Retirement Fund’s holdings in Axon Enterprise were worth $2,277,000 as of its most recent SEC filing.
Other institutional investors also recently added to or reduced their stakes in the company. Trust Co. of Vermont bought a new position in Axon Enterprise during the second quarter valued at about $28,000. SJS Investment Consulting Inc. bought a new position in Axon Enterprise during the third quarter valued at about $30,000. Sandy Spring Bank grew its position in Axon Enterprise by 230.0% during the second quarter. Sandy Spring Bank now owns 330 shares of the biotechnology company’s stock valued at $31,000 after buying an additional 230 shares during the period. Crewe Advisors LLC bought a new position in Axon Enterprise during the second quarter valued at about $37,000. Finally, Covestor Ltd grew its position in Axon Enterprise by 1,125.7% during the first quarter. Covestor Ltd now owns 429 shares of the biotechnology company’s stock valued at $59,000 after buying an additional 394 shares during the period. Institutional investors own 75.62% of the company’s stock.
Wall Street Analyst Weigh In
Several equities analysts recently weighed in on the stock. Needham & Company LLC increased their price target on shares of Axon Enterprise from $130.00 to $200.00 and gave the company a “buy” rating in a research report on Wednesday, November 9th. Credit Suisse Group increased their target price on shares of Axon Enterprise from $152.00 to $200.00 and gave the stock an “outperform” rating in a research report on Tuesday, January 10th. Robert W. Baird increased their target price on shares of Axon Enterprise from $170.00 to $200.00 in a research report on Thursday, December 15th. StockNews.com began coverage on shares of Axon Enterprise in a research report on Wednesday, October 12th. They set a “hold” rating for the company. Finally, Northland Securities increased their target price on shares of Axon Enterprise from $140.00 to $160.00 in a research report on Wednesday, November 9th. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $181.13.
Insider Activity at Axon Enterprise
In related news, Director Matthew R. Mcbrady sold 1,699 shares of the firm’s stock in a transaction that occurred on Friday, November 11th. The shares were sold at an average price of $182.88, for a total value of $310,713.12. Following the sale, the director now directly owns 5,651 shares of the company’s stock, valued at $1,033,454.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Axon Enterprise news, President Luke Larson sold 732 shares of Axon Enterprise stock in a transaction that occurred on Thursday, December 1st. The shares were sold at an average price of $178.00, for a total transaction of $130,296.00. Following the transaction, the president now directly owns 281,151 shares of the company’s stock, valued at $50,044,878. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Matthew R. Mcbrady sold 1,699 shares of Axon Enterprise stock in a transaction that occurred on Friday, November 11th. The stock was sold at an average price of $182.88, for a total transaction of $310,713.12. Following the transaction, the director now directly owns 5,651 shares in the company, valued at $1,033,454.88. The disclosure for this sale can be found here. Insiders have sold 101,429 shares of company stock valued at $18,596,402 over the last three months. 6.90% of the stock is owned by corporate insiders.
Axon Enterprise Trading Up 1.0 %
Shares of Axon Enterprise stock opened at $184.06 on Friday. Axon Enterprise, Inc. has a 12-month low of $82.49 and a 12-month high of $193.85. The company has a market cap of $13.10 billion, a price-to-earnings ratio of 126.94 and a beta of 0.79. The company has a current ratio of 2.79, a quick ratio of 2.39 and a debt-to-equity ratio of 0.01. The company’s 50-day moving average price is $177.40 and its 200-day moving average price is $144.65.
Axon Enterprise (NASDAQ:AXON – Get Rating) last announced its quarterly earnings results on Tuesday, November 8th. The biotechnology company reported $0.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.06 by $0.24. The firm had revenue of $311.75 million for the quarter, compared to the consensus estimate of $276.99 million. Axon Enterprise had a net margin of 9.75% and a return on equity of 9.88%. On average, equities analysts expect that Axon Enterprise, Inc. will post 0.54 earnings per share for the current fiscal year.
Axon Enterprise Company Profile
Axon Enterprise, Inc engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services.
Featured Articles
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axon Enterprise, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Axon Enterprise wasn’t on the list.
While Axon Enterprise currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
